Isomorphic Labs Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
350
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Investors
-
7
Isomorphic Labs General Information
Description
Operator of a digital biology company intended to redefine drug discovery with the power of artificial intelligence. The company reimagines the entire drug discovery process from first principles with an AI-first approach and ultimately aims to model and understand some fundamental mechanisms of life, enabling research institutions and healthcare organizations to improve healthcare outcomes by identifying targeted therapies with higher success rates and potentially lower costs.
Contact Information
Website
www.isomorphiclabs.comCorporate Office
- 280 Bishopsgate
- London EC2M 4RB
- England, United Kingdom
Corporate Office
- 280 Bishopsgate
- London EC2M 4RB
- England, United Kingdom
Isomorphic Labs Timeline
Isomorphic Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | Upcoming | Generating Revenue | ||||
| 2. Later Stage VC (Series B) | 12-May-2026 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 31-Mar-2025 | $579M | $579M | Completed | Generating Revenue |
Isomorphic Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Isomorphic Labs Patents
Isomorphic Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026131690-A1 | Molecular property prediction using molecule protonation states | Pending | 19-Dec-2024 | ||
| WO-2026114715-A1 | Scoring predicted three-dimensional (3d) structures of molecular systems | Pending | 27-Nov-2024 | ||
| WO-2026099134-A1 | Physics-based guidance for molecular structure prediction using generative diffusion models | Pending | 07-Nov-2024 | ||
| WO-2026098969-A1 | Training generative machine learning models on molecular dynamics simulation data | Pending | 05-Nov-2024 | ||
| WO-2026093340-A1 | Synthetic data generation using matched molecular pairs | Pending | 31-Oct-2024 | G16C20/70 |
Isomorphic Labs Signals
Isomorphic Labs Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CapitalG | Growth/Expansion | Minority | ||
| MGX | Other | Minority | ||
| Sovereign AI(Britain) | Government | Minority | ||
| Temasek Trust Capital | Impact Investing | Minority | ||
| Alphabet | Holding Company | Minority |
Isomorphic Labs FAQs
-
When was Isomorphic Labs founded?
Isomorphic Labs was founded in 2021.
-
Where is Isomorphic Labs headquartered?
Isomorphic Labs is headquartered in London, United Kingdom.
-
What is the size of Isomorphic Labs?
Isomorphic Labs has 350 total employees.
-
What industry is Isomorphic Labs in?
Isomorphic Labs’s primary industry is Drug Discovery.
-
Is Isomorphic Labs a private or public company?
Isomorphic Labs is a Private company.
-
What is Isomorphic Labs’s current revenue?
The current revenue for Isomorphic Labs is .
-
How much funding has Isomorphic Labs raised over time?
Isomorphic Labs has raised $2.68B.
-
Who are Isomorphic Labs’s investors?
CapitalG, MGX, Sovereign AI(Britain), Temasek Trust Capital, and Alphabet are 5 of 7 investors who have invested in Isomorphic Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process